
Hong Kong has built a reputation as a serious jurisdiction for intellectual property. The city ranks among Asia's top IP trading hubs, with policy initiatives designed to attract patent and IP-intensive businesses from around the world. But if you are considering a Hong Kong IP holding company, the picture is more nuanced than many advisers let on. Royalty and IP income can be taxed in Hong Kong, and the Foreign-Sourced Income Exemption (FSIE) regime can pull offshore IP income into charge unless you meet strict nexus and substance conditions. The headline profits tax rate is not zero: it is 8.25 per cent on the first HKD 2 million and 16.5 per cent above that. Getting the structure right matters enormously, and getting it wrong can mean double taxation, penalties, or both. This article covers the tax treatment, substance expectations, licensing structures, and common mistakes so you can make an informed decision rather than an expensive one.
Why hold intellectual property in Hong Kong
Hong Kong offers a few genuine advantages for IP-intensive groups. The city has a common law legal system, strong contract enforcement, and a well-developed IP registration framework. It has signed comprehensive double taxation agreements with over 40 jurisdictions, which can reduce withholding tax on royalty payments flowing into the territory. The global growth powered by IP protection is something the Hong Kong government has actively supported through its IP trading centre and patent box proposals.
There is no capital gains tax, no VAT, and no withholding tax on dividends paid out of Hong Kong. For groups that genuinely develop or manage IP in the territory, this combination can be attractive. The territorial tax system means that only profits sourced in Hong Kong are taxable, though the FSIE rules have significantly tightened how that principle applies to passive income like royalties.
The city also sits at the centre of Asia-Pacific supply chains, which matters if your IP is licensed to operating companies in the region. Time zone alignment, professional services depth, and proximity to mainland China all count for something practical. But none of these advantages work in your favour if the structure lacks real commercial substance.
Tax on IP and royalty income, and the FSIE IP rules
Hong Kong's two-tier profits tax applies to IP income sourced in the territory: 8.25 per cent on the first HKD 2 million of assessable profits and 16.5 per cent on the rest. Royalty income is not exempt simply because the IP was created or registered elsewhere. The Inland Revenue Department looks at where the activities generating the income actually took place.
For royalties received from outside Hong Kong, the FSIE regime is the critical framework. Since its expansion, passive income including IP royalties received by a Hong Kong entity from a non-Hong Kong source can be deemed taxable unless the company satisfies specific exemption conditions. The updated proposals for enhanced IP tax deductions introduced in 2026 refine the deduction rules for capital expenditure on IP, but they do not remove the FSIE obligations.
Under the FSIE IP rules, a company receiving foreign-sourced IP income must demonstrate that it meets the nexus requirement (discussed below) to claim exemption. If the nexus test is not satisfied, that income is treated as taxable in Hong Kong at the standard profits tax rate. This is a far cry from the blanket zero-tax narrative some promoters still push. The KPMG analysis of the updated IP deduction regime confirms the direction of travel: Hong Kong is aligning more closely with OECD standards, not moving away from them.
Substance and the nexus requirement
The nexus approach, borrowed from the OECD's modified nexus framework, ties the tax benefit to where qualifying R&D expenditure actually occurs. In simple terms, if a Hong Kong licensing company wants to claim FSIE exemption on its IP income, it must show that a sufficient proportion of the qualifying expenditure on developing that IP was incurred by the company itself, or by related parties within Hong Kong.
This is not a box-ticking exercise. The Inland Revenue Department expects to see real people making real decisions about the IP in Hong Kong. That means qualified employees or directors who understand the IP, documented board decisions about licensing strategy, and evidence that the company is not merely a conduit.
What does adequate substance look like in practice?
- Staff or directors in Hong Kong with genuine expertise in the IP being held
- Board meetings held in the territory with documented minutes showing strategic IP decisions
- Local expenditure on IP development, maintenance, or enhancement
- Control over licensing negotiations and enforcement, not just passive receipt of royalties
Groups that treat the Hong Kong entity as a letterbox and park IP there without any operational reality are asking for trouble. Tax authorities in both Hong Kong and the jurisdictions paying royalties are increasingly sharing information and scrutinising these arrangements. Cosmos works with licensed local partners to help clients establish the kind of genuine presence that withstands this scrutiny, rather than assembling a paper structure that falls apart under audit.
Licensing structures, at a high level
A typical IP licensing arrangement through Hong Kong involves the Hong Kong entity owning or sub-licensing the IP and granting licences to operating companies in other jurisdictions. The operating companies pay royalties to the Hong Kong entity, which reports that income and claims any applicable FSIE exemption or treaty benefits.
There are several common variations:
- A principal structure where the Hong Kong company owns the IP outright and licenses it to subsidiaries or third parties across Asia-Pacific
- A sub-licensing model where the IP is owned by a parent company elsewhere and sub-licensed through Hong Kong to take advantage of treaty networks and lower withholding tax rates
- A cost-sharing arrangement where the Hong Kong entity co-funds R&D and receives a share of IP ownership proportional to its contribution
Each of these structures must be supported by intercompany agreements that reflect arm's length pricing. Generic templates downloaded from the internet will not survive a transfer pricing audit. The royalty rates must be benchmarked against comparable transactions, and the legislative council papers on IP commercialisation make clear that Hong Kong is building institutional capacity to review these arrangements more rigorously.
If you are also considering the UAE for IP holding, the two jurisdictions can complement each other depending on your group's geography and substance footprint. The key is matching the structure to where the real activity happens, not chasing the lowest headline rate.
The risks, and what to get right
The most common mistake is treating a Hong Kong IP holding arrangement as a pure tax play with no operational reality. This creates risk on multiple fronts.
First, the Hong Kong Inland Revenue Department can deny FSIE exemption if the nexus requirement is not met, leaving you with a full profits tax charge on income you assumed was exempt. Second, the jurisdiction paying the royalties may challenge the deductibility of those payments if the Hong Kong entity lacks substance, meaning you pay tax twice. Third, under the global minimum tax rules now being implemented across many jurisdictions, a low-substance IP holding company may trigger top-up taxes that eliminate any benefit entirely.
Getting it right means investing in proper setup from the start:
- Commission a bespoke transfer pricing study before the first royalty payment flows
- Ensure the intercompany licence agreement is drafted by qualified counsel, not copied from a template
- Build genuine substance in Hong Kong: staff, premises, decision-making
- Monitor ongoing compliance with FSIE conditions annually, not just at setup
- Keep contemporaneous documentation of all IP-related decisions made in Hong Kong
Cosmos helps clients structure these arrangements through licensed local partners who understand both the Hong Kong regulatory environment and the cross-border implications. The goal is a structure that works commercially and survives scrutiny, not one that looks clever on paper for six months.
The R&D tax incentives available in Hong Kong can also play a role, providing enhanced deductions for qualifying expenditure that simultaneously strengthens your nexus position. Aligning your R&D spending with your IP holding location is one of the most effective ways to build a defensible structure.
Frequently asked questions
Can you hold IP in Hong Kong tax-efficiently?
Yes, but tax-efficiently does not mean tax-free. Hong Kong's profits tax applies to IP income sourced in the territory, and the FSIE regime can bring foreign-sourced IP income into charge if the nexus requirement is not met. A well-structured arrangement with genuine substance and proper transfer pricing can be highly efficient, but it requires real investment in people, processes, and documentation.
Is royalty income taxed in Hong Kong?
Royalty income sourced in Hong Kong is subject to profits tax at 8.25 per cent on the first HKD 2 million and 16.5 per cent thereafter. Foreign-sourced royalty income may be exempt under FSIE rules if the company satisfies the nexus approach, but this is not automatic. You need qualifying R&D expenditure and demonstrable substance in the territory.
What substance is needed for a Hong Kong IP holding entity?
The IP experts operating in Hong Kong emphasise that substance means qualified people making genuine decisions about the IP. This includes local staff or directors with relevant expertise, documented board meetings, control over licensing strategy, and meaningful expenditure on IP development or management. A registered address and a company secretary alone will not satisfy the requirement.
How does Hong Kong compare to the UAE for IP holding?
Both jurisdictions offer advantages, but they suit different profiles. Hong Kong has a broader treaty network and a mature legal system for IP enforcement. The UAE offers its own incentives, particularly in free zones. Some groups use both, licensing IP through Hong Kong into Asia-Pacific and through the UAE into other regions. The right choice depends on where your substance, customers, and R&D activity actually sit. Cosmos can help you evaluate both options through its network of licensed partners in each jurisdiction.
This is general information, not tax or legal advice. Confirm your position with a qualified adviser before acting.


.avif)


.avif)

.avif)






